본문으로 건너뛰기
← 뒤로

Correction: TACE-HAlC combined with Donafenib and immune checkpoint inhibitors for BCLC stage C HCC patients (THEME study): a retrospective IPTW-adjusted cohort study.

코호트 1/5 보강
Frontiers in immunology 📖 저널 OA 100% 2021: 2/2 OA 2022: 13/13 OA 2023: 10/10 OA 2024: 62/62 OA 2025: 810/810 OA 2026: 522/522 OA 2021~2026 2025 Vol.16() p. 1745867
Retraction 확인
출처

Yin L, Li W, Shao W, Hou X, Liu B, Liu X

📝 환자 설명용 한 줄

[This corrects the article DOI: 10.3389/fimmu.2025.1669856.].

이 논문을 인용하기

↓ .bib ↓ .ris
APA Yin L, Li W, et al. (2025). Correction: TACE-HAlC combined with Donafenib and immune checkpoint inhibitors for BCLC stage C HCC patients (THEME study): a retrospective IPTW-adjusted cohort study.. Frontiers in immunology, 16, 1745867. https://doi.org/10.3389/fimmu.2025.1745867
MLA Yin L, et al.. "Correction: TACE-HAlC combined with Donafenib and immune checkpoint inhibitors for BCLC stage C HCC patients (THEME study): a retrospective IPTW-adjusted cohort study.." Frontiers in immunology, vol. 16, 2025, pp. 1745867.
PMID 41357222 ↗

Abstract

[This corrects the article DOI: 10.3389/fimmu.2025.1669856.].

🏷️ 키워드 / MeSH 📖 같은 키워드 OA만

같은 제1저자의 인용 많은 논문 (5)

🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반

🟢 PMC 전문 열기